Experience

• 

  Illumina

  • United States
  • Biotechnology Research
  • 700 & Above Employee

  • Director, R&D Program Management

    • Sep 2021 - Present

  • Associate Director Program Management

    • Sep 2014 - Sep 2021

• 

  Hologic

  • San Diego

  • Associate Director Program Management

    • 2007 - Aug 2014
    • San Diego

    • Led the execution of three Oncology product development projects through leadership and oversite of cross-functional core teams; resulted in CE and US IVD PMA approval of PCA3 biomarker for prostate cancer• Supported strategic discussions regarding the Oncology portfolio with resource, project cost and timeline estimates• Generated and managed project budgets• Lead cross functional team to develop multiple respiratory assays on new instrument with new consumables and manufacturing processes

• 

  Hologic (Formerly Gen-Probe)

  • United States
  • Biotechnology Research
  • 500 - 600 Employee

  • Senior Program Manager

    • 2005 - 2007

    • Led first Oncology biomarker (PCA3) program from research to commercial ASR launch on time and on budget• Spearheaded the strategy for clinical research studies to support Oncology biomarker PCA3• Key member of Oncology business unit that determined strategic direction including licensing of a second prostate cancer biomarker – TMPRSS2:ERG

  • Senior Staff Sceintist

    • 2002 - 2005

    • Lead effort for quantitative viral projects on TIGRIS• Technical lead and Core Team leader for new prostate biomarker, PCA3:develop dual quantitative TMA assay• Lead efforts of 8-9 scientists and technicians

  • Staff Scientist

    • 1999 - 2002

    • Lead technical efforts for feasibility studies for quantitative HIV and HCV viral load assays – incorporation of internal control, extend dynamic range, improve subtype detection• R&D technical lead and Core Team lead for quantitative HCV ASR project – launch product that is still on the market• Key member of strategy team for Viral Diagnostics program• Lead research studies with collaborators for the HIV-1 viral load assay• Lead assay integration efforts for some studies for the CT/GC on TIGRIS program• Led R&D team of 6-8 scientists and technician

  • Senior Research Scientist

    • 1996 - 1999

    • R&D technical lead and Core Team lead for quantitative HIV program• Responsible for the development efforts of the quantitative HIV-1 viral load assay• Initiate multiple research studies with collaborators for the HIV-1 viral load assay• Led R&D team of 5-6 scientists and technicians• Initiate Design Control efforts for quantitative HIV-1 program

  • Research Scientist

    • 1994 - 1996

    • Technical work and supervision of 2 technicians in the development and product improvement of assays for chlamydia trachomatis

• 

  Sanford-Burnham Medical Research Institute

  • La Jolla, CA

  • Post Doctoral Fellow

    • Jun 1993 - Nov 1994
    • La Jolla, CA

    Cancer research - Role of genes involved in apoptosis

• 

  Walter and Eliza Hall Institute of Medical Research

  • Victoria, Australia

  • Post Doctoral Fellow

    • Mar 1991 - Mar 1993
    • Victoria, Australia

    Cancer research - Cell cylce regulation related to B and T cell cancer; generate transgenic mouse model

• 

  University of Western Ontario

  • London, Canada

  • Research Technician

    • 1983 - 1984
    • London, Canada